Trial intelligence / Profile preview

Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone for prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery

IRCT20171216037910N2Phase 3Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Jun 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of ondansetron, metoclopramide and dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Rate of postoperative nausea and vomiting after laparoscopic surgery. Started Jun 2017; status: completed.

02

Drugs

ondansetronmetoclopramidedexamethasone
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20171216037910N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171216037910N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call